RedHill Biopharma Ltd. RDHL
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.41$0.45
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 286.00K | 3.02M | 5.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 286.00K | 3.02M | 5.76M |
| Cost of Revenue | -- | -- | -- | -- | 1.79M |
| Gross Profit | -- | -- | 286.00K | 286.00K | 3.97M |
| SG&A Expenses | -- | -- | 2.72M | -4.64M | 9.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 3.68M | -5.50M | 12.96M |
| Operating Income | -- | -- | -3.39M | 483.00K | -7.20M |
| Income Before Tax | -- | -- | -2.94M | 3.10M | -8.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -2.94 | 3.10 | -8.12 |
| Earnings from Discontinued Operations | -- | -- | -1.20M | -1.20M | -1.20M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -4.13M | -6.72M | -9.31M |
| EBIT | -- | -- | -3.39M | 483.00K | -7.20M |
| EBITDA | -- | -- | -3.23M | 491.00K | -6.92M |
| EPS Basic | -- | -- | -45.84K | -54.69K | -63.12K |
| Normalized Basic EPS | -- | -- | -1.02 | 1.48 | -2.39 |
| EPS Diluted | -- | -- | -45.84K | -54.69K | -63.12K |
| Normalized Diluted EPS | -- | -- | -1.02 | 1.48 | -2.39 |
| Average Basic Shares Outstanding | -- | -- | 6.77M | 4.84M | 6.18M |
| Average Diluted Shares Outstanding | -- | -- | 600.00 | 400.00 | 400.00 |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |